September 28, 2026
OpenEvidence
OpenEvidence, which previously focused on 'ChatGPT for Doctors,' raised $250 million in Series D funding and has quietly pivoted into drug development.
- Round
- Series D
- Amount raised
- $250M
- Lead investor
- —
- Industry
- Biotechnology
- Headquarters
- United States
- Employees
- 11-50 employees
- Website
- openevidence.com
- View profile →